Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Free Cash Flow Generation Index
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Free Cash Flow Generation Index of 0.93x as of December 2025. Free cash flow of CN¥267.70 Million represents 1% of operating cash flow (CN¥287.81 Million). Explore Tianjin Lisheng Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Lisheng Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tianjin Lisheng Pharmaceutical Co Ltd.
Annual Free Cash Flow Generation for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Tianjin Lisheng Pharmaceutical Co Ltd. Check Tianjin Lisheng Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥414.39 Million | CN¥451.85 Million | CN¥37.46 Million | ▲ +134.5% |
| 2024 | 0.39x | CN¥34.51 Million | CN¥88.26 Million | CN¥53.75 Million | ▼ -40.8% |
| 2023 | 0.66x | CN¥138.29 Million | CN¥209.51 Million | CN¥61.72 Million | ▼ -24.7% |
| 2022 | 0.88x | CN¥290.47 Million | CN¥331.38 Million | CN¥40.91 Million | ▲ +59.2% |
| 2021 | 0.55x | CN¥108.10 Million | CN¥196.34 Million | CN¥88.24 Million | ▲ +273.1% |
| 2020 | -0.32x | CN¥-24.29 Million | CN¥76.37 Million | CN¥100.66 Million | ▼ -148.0% |
| 2019 | 0.66x | CN¥177.87 Million | CN¥268.33 Million | CN¥90.46 Million | ▲ +85.1% |
| 2018 | 0.36x | CN¥58.26 Million | CN¥162.69 Million | CN¥104.43 Million | ▼ -50.3% |
| 2017 | 0.72x | CN¥129.16 Million | CN¥179.25 Million | CN¥50.09 Million | ▲ +243.7% |
| 2016 | 0.21x | CN¥36.40 Million | CN¥173.60 Million | CN¥137.20 Million | ▲ +741.7% |
| 2015 | -0.03x | CN¥-6.47 Million | CN¥198.13 Million | CN¥204.60 Million | ▲ +98.9% |
| 2014 | -3.02x | CN¥-218.41 Million | CN¥72.24 Million | CN¥290.65 Million | ▼ -3627.3% |
| 2013 | -0.08x | CN¥-23.49 Million | CN¥289.62 Million | CN¥313.11 Million | ▼ -177.1% |
| 2012 | 0.11x | CN¥26.38 Million | CN¥250.72 Million | CN¥224.35 Million | ▲ +145.2% |
| 2011 | -0.23x | CN¥-31.36 Million | CN¥134.58 Million | CN¥165.94 Million | ▼ -137.2% |
| 2010 | 0.63x | CN¥116.87 Million | CN¥186.55 Million | CN¥69.69 Million | ▼ -31.2% |
| 2009 | 0.91x | CN¥178.55 Million | CN¥196.14 Million | CN¥17.60 Million | ▲ +86.7% |
| 2008 | 0.49x | CN¥61.73 Million | CN¥126.59 Million | CN¥64.86 Million | ▼ -47.0% |
| 2007 | 0.92x | CN¥161.02 Million | CN¥174.94 Million | CN¥13.92 Million | — |